Market closed
Fresenius Medical Care AG/€FME
08:00
09:15
10:30
11:45
13:00
1D1W1MYTD1Y5YMAX
About Fresenius Medical Care AG
Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.
Ticker
€FME
Sector
Trading on
XETRA
Industry
Health Care Providers & Services
Headquarters
Employees
113,079
Website
FME Metrics
BasicAdvanced
€13B
Market cap
19.71
P/E ratio
€2.25
EPS
0.85
Beta
€1.19
Dividend rate
2.69%
Dividend yield
Price and volume
Market cap
€13B
Beta
0.85
52-week high
€45.69
52-week low
€32.51
Average daily volume
519K
Dividend rate
€1.19
Financial strength
Current ratio
1.374
Quick ratio
0.784
Long term debt to equity
64.622
Total debt to equity
75.906
Dividend payout ratio (TTM)
52.99%
Interest coverage (TTM)
4.33%
Management effectiveness
Return on assets (TTM)
2.98%
Return on equity (TTM)
5.82%
Valuation
Price to earnings (TTM)
19.715
Price to revenue (TTM)
0.675
Price to book
0.88
Price to tangible book (TTM)
-17.46
Price to free cash flow (TTM)
8.446
Dividend yield (TTM)
2.69%
Forward dividend yield
2.69%
Growth
Revenue change (TTM)
-1.15%
Earnings per share change (TTM)
46.47%
3-year revenue growth (CAGR)
3.46%
3-year earnings per share growth (CAGR)
-10.51%
3-year dividend per share growth (CAGR)
-3.88%
What the Analysts think about FME
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Fresenius Medical Care AG stock.
FME Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
FME Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
FAQs
What’s the current market cap for Fresenius Medical Care AG stock?
Fresenius Medical Care AG (FME) has a market cap of €13B as of December 31, 2024.
What is the P/E ratio for Fresenius Medical Care AG stock?
The price to earnings (P/E) ratio for Fresenius Medical Care AG (FME) stock is 19.71 as of December 31, 2024.
Does Fresenius Medical Care AG stock pay dividends?
Yes, the Fresenius Medical Care AG (FME) stock pays dividends to shareholders. As of December 31, 2024, the dividend rate is €1.19 and the yield is 2.69%. Fresenius Medical Care AG has a payout ratio of 52.99% on a trailing twelve-month basis.
When is the next Fresenius Medical Care AG dividend payment date?
The next Fresenius Medical Care AG (FME) dividend payment date is unconfirmed.
What is the beta indicator for Fresenius Medical Care AG?
Fresenius Medical Care AG (FME) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.